Advent International has agreed to acquire a controlling position in Bharat Serums and Vaccines, an Indian biopharmaceuticals supplier focused on the women’s health segment.
The transaction will facilitate full exits for OrbiMed Advisors and Kotak Private Equity, which reportedly hold a combined 23% stake. OrbiMed invested $14 million in the company in 2010, according to AVCJ...
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Kurt Bjorklund, a co-managing partner at Permira, explains how a sector-focused investment style is becoming indispensable in Asia’s competitive and disruption-prone markets
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Food delivery start-up Delivery Hero has agreed to acquire Korean peer Woowa Brothers in a deal that values the target at $4 billion and will facilitate exits for several private equity investors.